310
Participants
Start Date
April 30, 2011
Primary Completion Date
December 31, 2012
Study Completion Date
May 31, 2013
etanercept
Administered by subcutaneous injection
Topical agents
"Topical agents prescribed at the discretion of the Principal Investigator and were are limited to the following:~* hydrocortisone 2.5%~* betamethasone valerate 0.1%~* betamethasone dipropionate 0.05%~* clobetasol 0.05%~* calcitriol~* calcipotriol plus betamethsone dipropionate 0.05%"
Research Site, Calgary
Research Site, Surrey
Research Site, Vancouver
Research Site, Winnipeg
Research Site, Moncton
Research Site, St. John's
Research Site, St. John's
Research Site, Halifax
Research Site, Courtice
Research Site, Greater Sudbury
Research Site, Markham
Research Site, Mississauga
Research Site, North Bay
Research Site, Peterborough
Research Site, Richmond Hill
Research Site, Toronto
Research Site, Toronto
Research Site, Waterloo
Research Site, Windsor
Research Site, Montreal
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Saint-Hyacinthe
Lead Sponsor
Amgen
INDUSTRY